Elevated Bromide Levels Due to Tazemetostat Therapy Treated With Salt and Water Supplementation in Two Children With Atypical Teratoid Rhabdoid Tumor
Open Access
- 19 May 2025
- journal article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 72 (8) , e31803
Abstract
Atypical teratoid rhabdoid tumor (ATRT) is an embryonal CNS tumor that afflicts young children. The molecular process associated with ATRT is loss of SMARCB1 or SMARCA4, which causes EZH2 overactivation. Tazemetostat hydrobromide is an EZH2 inhibitor, which has shown efficacy in the treatment of ATRT. Tazemetostat is produced as a bromide salt and can cause increased bromide levels that may require therapy cessation or dose reduction. We report two children with ATRT, who developed elevated bromide levels secondary to tazemetostat, which were treated with chloride. We propose consideration of salt supplementation in children receiving tazemetostat to prevent bromide elevation and pauses or reductions in therapy.Keywords
This publication has 10 references indexed in Scilit:
- Tazemetostat in the therapy of pediatric INI1-negative malignant rhabdoid tumorsScientific Reports, 2023
- Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621CJNCI: Journal of the National Cancer Institute, 2023
- Bromism in the Modern Day: Case Report and Canadian Review of Bromide IntoxicationJournal of General Internal Medicine, 2020
- Case-based review: atypical teratoid/rhabdoid tumorNeuro-Oncology Practice, 2018
- SMARCB1-deficient Tumors of Childhood: A Practical GuidePediatric and Developmental Pathology, 2017
- Approach to the Patient With a Negative Anion GapAmerican Journal of Kidney Diseases, 2016
- Bromide Toxicity from Consumption of Dead Sea SaltThe American Journal of Medicine, 2010
- Case files of the medical toxicology fellowship at the New York City Poison Control: Bromism: Forgotten, but not goneJournal of Medical Toxicology, 2009
- Effect of Salt Intake on Renal Excretion of Water in HumansHypertension, 2001
- TREATMENT OF BROMIDE POISONING COMPARISON OF FORCED HALOGEN TURNOVER AND HÆMODIALYSISThe Lancet, 1963